Seoul, South Korea

Maddeboina Krishnaiah



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Maddeboina Krishnaiah in Medical Treatments

Introduction

Maddeboina Krishnaiah is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing serious health conditions such as fibrosis, cancer, and vascular injuries. His innovative approach has the potential to change the landscape of treatment options available to patients.

Latest Patents

Krishnaiah holds a patent for his invention titled "Methods of treating fibrosis, cancer and vascular injuries." This invention focuses on the use of inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4) in treating, preventing, or reducing fibrosis, cancer, and vascular injuries. This groundbreaking work highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Krishnaiah is associated with the Ewha University-Industry Collaboration Foundation, where he continues to engage in research and development. His work at this institution allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Some of his notable coworkers include Dae-Kee Kim and Yhun Yhong Sheen. Their collaboration fosters a dynamic environment for research and innovation, enhancing the potential for impactful discoveries in medical treatments.

Conclusion

Maddeboina Krishnaiah's contributions to medical science through his innovative patents and collaborative efforts position him as a key figure in the fight against serious health conditions. His work exemplifies the importance of innovation in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…